On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management.

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology,” published in the January 2025 issue of Pain by ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

“Today’s approval is an important public health milestone in acute pain management,” said Jacqueline Corrigan-Curay, MD, acting director of the FDA’s Center for Drug Evaluation and ...

Arkansas Spine and Pain in Little Rock named E. Scot Davis as CEO, Talk Business & Politics reported Jan. 29.

Watertown, N.Y.-based Samaritan Health will close its pain management center Feb. 28, according to a news release from the health system. The center, which has 15 employees and one contracted ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

But there is growing awareness of the complexity of pain and the need for tailored management. Increasingly, patients are turning to pain clinics that offer that possibility: There, they can ...

I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the house listening to audiobooks and doing voice-to-text searches for ...